Right Ventricular Response During Exercise in Patients with Chronic Obstructive Pulmonary Disease.

Heart Lung Circ

Cardiology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Published: June 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aim: Right ventricular (RV) pump function is of essential clinical and prognostic importance in a variety of heart and lung diseases. While the evaluation of RV performance at rest has been implemented in the clinical setting, it is unknown whether this assessment during exercise may provide additional benefit. With this aim, we evaluated the exercise-induced pulmonary arterial systolic pressure (PASP) increase during exercise in patients with severe chronic obstructive pulmonary disease (COPD) as an expression of RV contractile reserve.

Method: Cardiopulmonary exercise testing (CPET) with synchronic echocardiography was performed in 81 patients. Patients were classified into two groups according to an exercise-induced PASP increase above 30mmHg (High PSAP) or below 30mmHg (Low PSAP) during maximal exercise. Patients were then followed for three years.

Results: Sixteen patients (20%) had low PSAP and 65 (80%) showed high PSAP. These were not significant clinical and functional differences. Low PSAP was associated with a significantly lower peak VO2 (mean (SD), 35 (2) % predicted) compared to high PSAP response (peak VO2 45 (3) % predicted), p=0.045. Factors associated with mortality were age and exercise-induced PASP. Seventeen patients died during the three years of follow-up (7 (39%) in the low PSAP group and only 10 (1%) in the high PSAP group, p=0.041).

Conclusion: Cardiopulmonary exercise testing with a synchronic echocardiography may be a useful tool for the assessment of RV contractile reserve in severe COPD patients. Exercise-induced PSAP emerges as a possible prognostic factor in these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hlc.2016.10.015DOI Listing

Publication Analysis

Top Keywords

high psap
16
low psap
16
exercise patients
12
patients
9
psap
9
chronic obstructive
8
obstructive pulmonary
8
pulmonary disease
8
pasp increase
8
cardiopulmonary exercise
8

Similar Publications

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical-Induced Murine MASH Model.

Kaohsiung J Med Sci

September 2025

Hepatitis Research Center, College of Medicine; Center for Metabolic Disorders and Obesity; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly prevalent chronic liver condition that can progress to severe complications such as metabolic dysfunction-associated steatohepatitis (MASH). Despite its growing burden, there are no reliable non-invasive biomarkers for tracking disease progression. In this study, we established a murine MASLD/MASH model using a high-fat diet and chemical (CCl) induction.

View Article and Find Full Text PDF

Novel Antibiotics: Niches, Efficacies, and Clinical Pearls.

J Infus Nurs

August 2025

Author Affiliations: PGY-1 Pharmacy Practice Resident (Dr Van), Infectious Diseases Clinical Pharmacy Specialist (Dr Lee), University of California, Irvine Medical Center; and School of Pharmacy and Pharmaceutical Sciences (Dr Johannesmeyer), University of California, Irvine.

View Article and Find Full Text PDF

Prosaposin: A Multifaceted Protein Orchestrating Biological Processes and Diseases.

Cells

July 2025

Key Laboratory of Exercise and Health Sciences of the Ministry of Education, Shanghai University of Sport, Shanghai 200438, China.

Prosaposin (PSAP), a multifunctional protein, plays a central role in various biological processes and diseases. It is the precursor of lysosomal activating protein, which is important for lipid metabolism and glucose metabolism. PSAP is implicated in cell signaling, neuroprotection, immunomodulation, and tumorigenesis.

View Article and Find Full Text PDF

Cellular Lyso-Gb3 Is a Biomarker for Mucolipidosis II.

Int J Mol Sci

June 2025

Department of Molecular and Genetic Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan.

Lysosomal storage diseases are caused by defective lysosomal function, such as impaired lysosomal enzyme activities, which include more than 70 different diseases. Although biomarkers and therapies have been developed to date for some of them, many others remain challenging to diagnose and treat. In this study, an elevated level of Globotriaosylsphingosine (Lyso-Gb3), an already known biomarker for Fabry disease, was confirmed in the knock-out cells of the , , and genes and models for Fabry, mucolipidosis II/III (ML II/III), and combined saposin deficiency, respectively.

View Article and Find Full Text PDF

Enriching trace biomarkers (e.g., proteins, nucleic acids) is critical for biomedical applications; yet conventional methods often lack versatility, limiting their effectiveness to specific biomarker types.

View Article and Find Full Text PDF